Terry Dagnon
2023
In 2023, Terry Dagnon earned a total compensation of $728.4K as Former Chief Operations Officer at Outlook Therapeutics, a 49% decrease compared to previous year.
Compensation breakdown
| Option Awards | $267,025 |
|---|---|
| Salary | $450,000 |
| Other | $11,358 |
| Total | $728,383 |
Dagnon received $450K in salary, accounting for 62% of the total pay in 2023.
Dagnon also received $267K in option awards and $11.4K in other compensation.
Rankings
In 2023, Terry Dagnon's compensation ranked 1,571st out of 3,006 executives tracked by ExecPay. In other words, Dagnon earned more than 47.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,571 out of 3,006 | 48th |
Division Manufacturing | 921 out of 1,650 | 44th |
Major group Chemicals And Allied Products | 596 out of 918 | 35th |
Industry group Drugs | 580 out of 881 | 34th |
Industry Biological Products, Except Diagnostic Substances | 157 out of 213 | 26th |
Source: SEC filing on February 8, 2024.
Dagnon's colleagues
We found two more compensation records of executives who worked with Terry Dagnon at Outlook Therapeutics in 2023.
News
Outlook Therapeutics CEO C Trenary's 2023 pay jumps 32% to $1.8M
February 8, 2024
Outlook Therapeutics Chief Operations Officer Terry Dagnon's 2022 pay jumps 378% to $1.4M
February 15, 2023
Outlook Therapeutics CEO C Trenary receives $7.5M in 2021
January 27, 2022
Outlook Therapeutics CEO Lawrence Kenyon's 2020 pay falls 36% to $1.2M
February 22, 2021